Soluble monomeric human programmed cell death-ligand 1 inhibits the functions of activated T cells
Liang, Zhaoduan, Chen, Wenfang, Guo, Yunzhuo, Ren, Yuefei, Tian, Ye, Cai, Wenxuan, Bao, Yifeng, Liu, Qi, Ding, Peng, Li, Yi
Published in Frontiers in immunology (17.05.2023)
Published in Frontiers in immunology (17.05.2023)
Get full text
Journal Article
A pilot study of lymphodepletion intensity for peripheral blood mononuclear cell-derived neoantigen-specific CD8 + T cell therapy in patients with advanced solid tumors
Li, Dandan, Chen, Chao, Li, Jingjing, Yue, Jianhui, Ding, Ya, Wang, Hailun, Liang, Zhaoduan, Zhang, Le, Qiu, Si, Liu, Geng, Gao, Yan, Huang, Ying, Li, Dongli, Zhang, Rong, Liu, Wei, Wen, Xizhi, Li, Bo, Zhang, Xiaoshi, Zhang, Xi, Xu, Rui-Hua
Published in Nature communications (10.06.2023)
Published in Nature communications (10.06.2023)
Get full text
Journal Article
STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells
Wang, Ling, Liang, Zhaoduan, Guo, Yunzhuo, Habimana, Jean de Dieu, Ren, Yuefei, Amissah, Obed Boadi, Mukama, Omar, Peng, Siqi, Ding, Xuanyan, Lv, Linshuang, Li, Junyi, Chen, Min, Liu, Zhaoming, Huang, Rongqi, Zhang, Yinchao, Li, Yi, Li, Zhiyuan, Sun, Yirong
Published in Cell death & disease (13.04.2024)
Published in Cell death & disease (13.04.2024)
Get full text
Journal Article
High‐affinity PD‐1 molecules deliver improved interaction with PD‐L1 and PD‐L2
Li, Yanyan, Liang, Zhaoduan, Tian, Ye, Cai, Wenxuan, Weng, Zhiming, Chen, Lin, Zhang, Huanling, Bao, Yifeng, Zheng, Hongjun, Zeng, Sihai, Bei, Chunhua, Li, Yi
Published in Cancer science (01.08.2018)
Published in Cancer science (01.08.2018)
Get full text
Journal Article
T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity
Cui, Yuanbin, Yuan, Tingjie, Wang, Ying, Zheng, Diwei, Qin, Le, Li, Shanglin, Jiang, Zhiwu, Lin, Shouheng, Guo, Wenjing, Wang, Zhi, Liang, Zhaoduan, Li, Yi, Yao, Yao, Liu, Xingguo, Tang, Qiannan, Tu, Hai-Yan, Zhang, Xu-Chao, Tang, Zhaoyang, Wong, Nathalie, Zhang, Zhenfeng, Qin, Dajiang, Thiery, Jean Paul, Xu, Kailin, Li, Peng
Published in Cell reports (Cambridge) (25.07.2023)
Published in Cell reports (Cambridge) (25.07.2023)
Get full text
Journal Article
Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-β in cultured hepatoma cells
Liang, Zhaoduan, Wu, Siyu, Li, Yuye, He, Li, Wu, Minhao, Jiang, Lifang, Feng, Lianqiang, Zhang, Ping, Huang, Xi
Published in PloS one (2011)
Published in PloS one (2011)
Get full text
Journal Article
In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma
Liu, Qi, Tian, Ye, Li, Yanyan, Zhang, Wei, Cai, Wenxuan, Liu, Yaju, Ren, Yuefei, Liang, Zhaoduan, Zhou, Peipei, Zhang, Yajing, Bao, Yifeng, Li, Yi
Published in Journal for immunotherapy of cancer (01.12.2020)
Published in Journal for immunotherapy of cancer (01.12.2020)
Get full text
Journal Article
Soluble programmed death ligand‐1‐induced immunosuppressive effects on chimeric antigen receptor‐natural killer cells targeting Glypican‐3 in hepatocellular carcinoma
Chen, Lin, Liu, Siyuan, Adah, Dickson, Sun, Qingyang, Liang, Zhaoduan, Ho, Mitchell, Sun, Beicheng
Published in Immunology (01.06.2023)
Published in Immunology (01.06.2023)
Get full text
Journal Article
Hydrophobic core evolution of major histocompatibility complex class I chain-related protein A for dramatic enhancing binding affinity
Cai, Wenxuan, Peng, Siqi, Tian, Ye, Bao, Yifeng, Liu, Qiang, Dong, Yan, Liang, Zhaoduan, Liu, Qi, Ren, Yuefei, Ding, Peng, Liu, Jinsong, Xu, Tingting, Li, Yi
Published in International journal of biological macromolecules (01.06.2024)
Published in International journal of biological macromolecules (01.06.2024)
Get full text
Journal Article
High-affinity human PD-L1 variants attenuate the suppression of T cell activation
Liang, Zhaoduan, Tian, Ye, Cai, Wenxuan, Weng, Zhiming, Li, Yanyan, Zhang, Huanling, Bao, Yifeng, Li, Yi
Published in Oncotarget (24.10.2017)
Published in Oncotarget (24.10.2017)
Get full text
Journal Article
A pilot study of lymphodepletion intensity for PBMC-derived, neoantigen-specific CD8+ T cells (Neo-Ts) therapy in patients with advanced solid tumors
Li, Dandan, Chen, Chao, Li, Jingjing, Yue, Jianhui, Ding, Ya, Wang, Hailun, Liang, Zhaoduan, Zhang, Le, Qiu, Si, Liu, Geng, Gao, Yan, Huang, Ying, Li, Dongli, Liu, Wei, Wen, Xizhi, Li, Bo, Zhang, Xiaoshi, Zhang, Xi, Xu, Rui-Hua
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Phase Ia clinical trial of adoptively transferring peripheral blood-derived cytotoxic T lymphocytes targeting individual neo-antigens to treat patients with advanced solid tumor
Li, Bo, Zhang, Xiaoshi, Liu, Geng, Qiu, Si, Liang, Zhaoduan, Liu, Mingming, Gao, Yan, Xu, Rui-hua
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells
Liang, Zhaoduan, Li, Yanyan, Tian, Ye, Zhang, Huanling, Cai, Wenxuan, Chen, Anan, Chen, Lin, Bao, Yifeng, Xiang, Bo, Kan, Heping, Li, Yi
Published in Cancer letters (10.04.2019)
Published in Cancer letters (10.04.2019)
Get full text
Journal Article
ImmTAC/Anti‐PD‐1 antibody combination to enhance killing of cancer cells by reversing regulatory T‐cell‐mediated immunosuppression
Zhang, Huanling, Li, Yanyan, Liu, Xiaoping, Liang, Zhaoduan, Yan, Mengyong, Liu, Qiang, Chen, Anan, Bao, Yifeng, Zhou, Chengzhi, Li, Shiyue, Yee, Cassian, Li, Yi
Published in Immunology (01.10.2018)
Published in Immunology (01.10.2018)
Get full text
Journal Article
Corrigendum to ‘High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells’ [Cancer Lett. 447 (2019) 164–173]
Liang, Zhaoduan, Li, Yanyan, Tian, Ye, Zhang, Huanling, Cai, Wenxuan, Chen, Anan, Chen, Lin, Bao, Yifeng, Xiang, Bo, Kan, Heping, Li, Yi
Published in Cancer letters (28.06.2019)
Published in Cancer letters (28.06.2019)
Get full text
Journal Article
Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors
Zhang, Huajun, Zhang, Jianbing, Chen, Lei, Weng, Zhiming, Tian, Ye, Zhao, Haifeng, Li, Youjia, Chen, Lin, Liang, Zhaoduan, Zheng, Hongjun, Zhao, Wenzhuo, Zhong, Shi, Li, Yi
Published in Journal of general virology (01.03.2017)
Published in Journal of general virology (01.03.2017)
Get full text
Journal Article
Imm TAC /Anti‐ PD ‐1 antibody combination to enhance killing of cancer cells by reversing regulatory T‐cell‐mediated immunosuppression
Zhang, Huanling, Li, Yanyan, Liu, Xiaoping, Liang, Zhaoduan, Yan, Mengyong, Liu, Qiang, Chen, Anan, Bao, Yifeng, Zhou, Chengzhi, Li, Shiyue, Yee, Cassian, Li, Yi
Published in Immunology (01.10.2018)
Published in Immunology (01.10.2018)
Get full text
Journal Article
Activation of Toll-Like Receptor 3 Impairs the Dengue Virus Serotype 2 Replication through Induction of IFN-[beta] in Cultured Hepatoma Cells
Liang, Zhaoduan, Wu, Siyu, Li, Yuye, He, Li, Wu, Minhao, Jiang, Lifang, Feng, Lianqiang, Zhang, Ping, Huang, Xi
Published in PloS one (04.08.2011)
Published in PloS one (04.08.2011)
Get full text
Journal Article